- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 29, 2026 | 35.92M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 35.49M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 35.3M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $14.65M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $14.23M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.21M |
| Capex | Q1 2026 · Mar 31, 2025 | $2.75M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $34.52M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $34.28M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $185.43M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $204.14M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $505.86M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $530.29M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $190.39M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $188.95M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.22B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.21B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.14B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.11B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $8.43B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.44B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $9.65B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.65B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.81 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.68 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.82 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.69 |
| Net Income | Q1 2026 · Mar 31, 2026 | $29.01M |
| Net Income | Q1 2026 · Mar 31, 2025 | $24.34M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $37.35M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $31.38M |
| Revenue | Q1 2026 · Mar 31, 2026 | $22.36M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $21.97M |